Clinical Trials

30 enrolled

Urinary Bladder Neoplasms

NCT00102544 2026-04-08

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

3,894 enrolled

Adenocarcinoma, Carcinoma, Renal Cell, von Hippel-Lindau Disease, Prostatic Neoplasms

NCT07205783 2026-04-07

Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)

40 enrolled

Prostatic Neoplasms

NCT02759744 2026-04-06

Fusion Guided Focal Laser Ablation of Prostate Cancer

30 enrolled

Phase 1 Enrolling by invitation

Prostatic Neoplasms

NCT07218003 2026-03-23

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

149 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT07488572 2026-03-23

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Phase 2 Enrolling by invitation

60 enrolled

Phase 1 Enrolling by invitation

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT05700461 2026-03-20

Drug Screening Using Novel IMD in Renal Cell Carcinoma

20 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT07474051 2026-03-16

PERSIST

GenitourinaryLymphoidOther hematologic neoplasm

178 enrolled

Prostatic Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05160480 2026-03-10

A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

BreastEndocrineGenitourinaryNET

9 enrolled

Breast Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors

NCT07454941 2026-03-06

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

4,000 enrolled

Carcinoma, Transitional Cell, Disease

NCT06238661 2026-03-05

ProScreenMRI

4,500 enrolled

Prostatic Neoplasms

NCT05195515 2026-03-03

CONQUER

2,000 enrolled

Urinary Bladder Neoplasms

NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

GastrointestinalGenitourinary

100 enrolled

Kidney Failure, Chronic, Pancreatic Neoplasms

NCT07439913 2026-02-27

Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer

120 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT04254133 2026-01-30

GIFTS

1,360 enrolled

Prostatic Neoplasms

NCT06243510 2026-01-28

CARE

90 enrolled

Urinary Bladder Neoplasms

NCT05443321 2026-01-23

Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes

GastrointestinalGenitourinary

1,006 enrolled

Arrhythmias, Cardiac, Asthma, Cardiovascular Diseases, Gastrointestinal Diseases, Heart Failure, Hematologic Diseases, Infections, Kidney Diseases, Nervous System Diseases, Rheumatic Diseases, Shock, Urologic Diseases, Critical Illness, Renal Insufficiency

NCT03181867 2026-01-21

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Phase 2 Enrolling by invitation

800 enrolled

Prostatic Neoplasms

NCT06472817 2026-01-21

Social Determinants of Migrant Health Factors Impacting Prostate Cancer Care and Survivorship Among Sub-Saharan African and Caribbean Immigrant Men

80 enrolled